IMVT
Immunovant, Inc. · Healthcare
General Counsel Mark S. Levine sold $115K of Immunovant, Inc.
Sold$114,778
$37.92Price
3,027Shares
−1%Stake
What IMVT did after the filing
- The stock from Mon, Jan 29 close, $39.32
- −19.9%
- S&P 500, same days
- +5.2%
Measured over 30 trading days, to the Mar 12 close.
Traded Fri, Jan 26. Filed Mon, Jan 29, 11:12 AM ET, during the session. Returns use the Jan 29 close and the Mar 12 close. Not investment advice.